Chronic transplant dysfunction (CTD) is the predominant cause of late graft failure. The common histopathological feature in all transplanted organs is intimal hyperplasia accompanied by organ specific lesions. The knowledge about CTD is incomplete, and there is no therapy to prevent or treat it. This review describes the current knowledge on the etiology of CTD, with emphasis on kidney transplants, and postulates a pathophysiologic route through which CTD may develop.
The problem of chronic transplant dysfunctionSince it was first shown in 1954 that successful transplantation of a healthy kidney could completely rehabilitate an individual with renal failure, transplantation of several organs has become an increasingly successful medical treatment for patients with end-stage organ failure. In 1998, in the Eurotransplant area alone, more than 3000 kidneys, 750 hearts, about 1000 livers, 230 lungs, and about 100 pancreas from cadaveric donors were transplanted [9]. Worldwide, 56 intestinal transplantations were performed in 1996 [70]. The shortterm results after clinical organ transplantation have improved progressively. This is principally due to refinements in tissue typing, advancements in organ preservation, operative techniques and ancillary care, more effective immunosuppressive agents, and better monitoring after engraftment. For example, one year survival of cadaveric kidneys has increased from approximately 50 % by the end of the 1960 s, to about 85 % nowadays 1671, and for living-related kidneys from 80% to Despite improving early results, however, it has become clear that clinical transplantation has not achieved its goal as a long-term treatment. For the period beyond one year, the annual rate of graft loss has changed less since the beginning of the experience. The half-life of cadaveric kidney allografts, for instance, has remained consistent at 7.5-9.5 years, although the latest United States Renal Data System (USRDS) data suggest that half-life of first cadaveric kidney grafts is improving (Figure 1) [68, 1461. Similarly, the half-life beyond the first year of heart transplants is 10.5 years [146]. Other organ transplants generally show comparable results, with exception of the liver, which shows more favourable long-term results [lo, 981.